Camp4 Therapeutics Inc (CAMP)

Currency in USD
1.44
+0.01(+0.70%)
Real-time Data·
CAMP Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
CAMP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.351.50
52 wk Range
1.3112.30
Key Statistics
Prev. Close
1.43
Open
1.43
Day's Range
1.35-1.5
52 wk Range
1.31-12.3
Volume
41.5K
Average Volume (3m)
124.52K
1-Year Change
-
Book Value / Share
2.56
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CAMP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
16.53
Upside
+1,047.92%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Camp4 Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Camp4 Therapeutics Inc Company Profile

Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-CPS-001, which is in a Phase 1 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-SYNGAP for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Compare CAMP to Peers and Sector

Metrics to compare
CAMP
Peers
Sector
Relationship
P/E Ratio
−0.6x−1.1x−0.5x
PEG Ratio
−0.01−0.040.00
Price/Book
0.6x2.2x2.6x
Price / LTM Sales
19.2x8.9x3.3x
Upside (Analyst Target)
-317.0%43.3%
Fair Value Upside
Unlock7.7%6.9%Unlock

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 16.53
(+1,047.92% Upside)

Earnings

Latest Release
May 13, 2025
EPS / Forecast
-0.62 / --
Revenue / Forecast
858.00K / --
EPS Revisions
Last 90 days

CAMP Income Statement

People Also Watch

2.41
INMB
-5.68%
0.373
ADIL
-1.92%
0.262
INTS
-2.85%
3.270
IMRX
+0.62%
0.97
GUTS
+0.89%

FAQ

What Stock Exchange Does Camp4 Therapeutics Trade On?

Camp4 Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Camp4 Therapeutics?

The stock symbol for Camp4 Therapeutics is "CAMP."

What Is the Camp4 Therapeutics Market Cap?

As of today, Camp4 Therapeutics market cap is 28.82M.

What Is Camp4 Therapeutics's Earnings Per Share (TTM)?

The Camp4 Therapeutics EPS (TTM) is -5.39.

When Is the Next Camp4 Therapeutics Earnings Date?

Camp4 Therapeutics will release its next earnings report on 02 Sept 2025.

From a Technical Analysis Perspective, Is CAMP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Camp4 Therapeutics Stock Split?

Camp4 Therapeutics has split 0 times.

How Many Employees Does Camp4 Therapeutics Have?

Camp4 Therapeutics has 55 employees.

What is the current trading status of Camp4 Therapeutics (CAMP)?

As of 11 Aug 2025, Camp4 Therapeutics (CAMP) is trading at a price of 1.44, with a previous close of 1.43. The stock has fluctuated within a day range of 1.35 to 1.50, while its 52-week range spans from 1.31 to 12.30.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.